Abstract
Recurrent, high-risk head and neck (HN) cancer patients experience poor local control and survival with the current treatment options such as external beam radiation, surgery or chemotherapy. Evaluation of the feasibility and efficacy of reirradiation using contemporary radiation techniques is limited. Recognizing the need for further investigation in these high-risk patients, we developed a pilot study of salvage surgery with adjuvant brachytherapy using Cs-131 implants. Here we describe the long-term outcomes of the novel use of Cs-131 brachytherapy with concurrent salvage surgery.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.